President-elect Trump has picked Marty Makary, a Johns Hopkins’s surgeon who has espoused contrarian views about the COVID-19 pandemic, to lead the Federal Drug Administration. Makary is a surgical oncologist at Johns Hopkins University and an author.

STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the Food and Drug Administration.

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.